Form 4: LeMaitre Vascular Insider Dividend Equivalent Accrual
Statement of Changes in Beneficial Ownership
Senior VP Trent G. Kamke reported the accrual of dividend equivalent rights related to existing equity awards.
Summary
- Trent G. Kamke, Senior V.P. of Operations at LeMaitre Vascular, Inc., reported the acquisition of dividend equivalent rights (DERs).
- A total of 11.8998 DERs were accrued across seven different equity award tranches.
- Each DER represents the economic equivalent of one share of common stock and vests proportionately with the underlying restricted stock units or performance share units.
- The transactions occurred on June 4, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing with no impact on the company's operational or financial outlook.
Positives
- Reflects ongoing alignment of executive compensation with shareholder interests through dividend participation.
Negatives
- None identified; this is a routine administrative disclosure of dividend accruals.
Risks
- None identified; this filing pertains to standard equity compensation maintenance.
Future Outlook
The filing does not provide forward-looking guidance regarding company operations or financial performance.
Industry Context
StockSavvy.ai notes that this is a standard regulatory disclosure for medical device companies, ensuring transparency regarding executive equity holdings and dividend participation.
Comparison to Industry Standards
- The disclosure follows standard SEC Section 16(a) reporting requirements for publicly traded U.S. companies.
- The use of dividend equivalent rights is a common practice in executive compensation packages to prevent dilution of incentive awards during dividend payments.
Stakeholder Impact
- Minimal impact; the filing confirms the standard maintenance of executive equity incentives.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 2022-12-12 | Grant date of initial RSU and PSU awards. |
| 2023-12-08 | Grant date of RSU and PSU awards. |
| 2024-12-06 | Grant date of RSU and PSU awards. |
| 2025-12-10 | Grant date of RSU award. |
| 2026-06-04 | Transaction date for dividend equivalent rights accrual. |
| 2026-06-05 | Filing date of the Form 4. |
Keywords
LeMaitre Vascular, LMAT, Insider Trading, Form 4, Dividend Equivalent Rights, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.